Literature DB >> 2675810

Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis.

M Laakso1, E Barrett-Connor.   

Abstract

We studied lipid and lipoprotein concentrations and their relationships to insulin level in 994 men and 1246 women ages 50 to 91 years in the upper middle-class community of Rancho Bernardo in southern California. Altogether, 593 men and 741 women had normal glucose tolerance, 240 men and 348 women, impaired glucose tolerance (IGT), 104 men and 117 women, newly diagnosed noninsulin-dependent diabetes (NIDDM), and 57 men and 40 women, previously diagnosed NIDDM. In women but not men, total cholesterol and low density lipoprotein were significantly higher in those with newly diagnosed NIDDM, compared to subjects with normal glucose tolerance. In both men and women, high density lipoprotein (HDL) cholesterol was significantly lower, and total triglyceride significantly higher, in subjects with IGT and NIDDM compared to those with normal glucose tolerance; these differences persisted after adjusting for age, body mass index, smoking, alcohol intake, and exercise level. Multiple linear-regression analyses showed that fasting insulin (but not 2-hour insulin) was significantly associated with low HDL cholesterol and high total triglycerides independently from other variables (age, body mass index, waist/hip ratio, alcohol intake, smoking, exercise, and 2-hour glucose). Overall, these results show that asymptomatic hyperglycemia (IGT, newly diagnosed NIDDM) is associated with lipid and lipoprotein changes favoring atherosclerosis and that fasting hyperinsulinemia (insulin resistance) is the most important factor associated with these lipid and lipoprotein abnormalities

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675810     DOI: 10.1161/01.atv.9.5.665

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  7 in total

1.  Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population.

Authors:  Prashantha Hebbar; Rasheeba Nizam; Motasem Melhem; Fadi Alkayal; Naser Elkum; Sumi Elsa John; Jaakko Tuomilehto; Osama Alsmadi; Thangavel Alphonse Thanaraj
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

2.  Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

Authors: 
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

3.  The Rancho Bernardo Study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection.

Authors:  Elizabeth Barrett-Connor
Journal:  Glob Heart       Date:  2013-06-01

4.  Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery.

Authors:  Y Yamasaki; R Kawamori; H Matsushima; H Nishizawa; M Kodama; M Kubota; Y Kajimoto; T Kamada
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

5.  The Triglyceride to HDL Ratio and Its Relationship to Insulin Resistance in Pre- and Postpubertal Children: Observation from the Wausau SCHOOL Project.

Authors:  Karen Olson; Bryan Hendricks; David K Murdock
Journal:  Cholesterol       Date:  2012-06-28

6.  Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.

Authors:  N Maneka G De Silva; Rachel M Freathy; Tom M Palmer; Louise A Donnelly; Jian'an Luan; Tom Gaunt; Claudia Langenberg; Michael N Weedon; Beverley Shields; Beatrice A Knight; Kirsten J Ward; Manjinder S Sandhu; Roger M Harbord; Mark I McCarthy; George Davey Smith; Shah Ebrahim; Andrew T Hattersley; Nicholas Wareham; Debbie A Lawlor; Andrew D Morris; Colin N A Palmer; Timothy M Frayling
Journal:  Diabetes       Date:  2011-01-31       Impact factor: 9.461

7.  Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes.

Authors:  Maki Tsujita; Mohammad Anwar Hossain; Rui Lu; Tomoe Tsuboi; Kuniko Okumura-Noji; Shinji Yokoyama
Journal:  J Atheroscler Thromb       Date:  2017-04-19       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.